A detailed history of Bank Of America Corp transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 146 shares of DARE stock, worth $49. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 274 46.72%
Holding current value
$49
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.31 - $0.57 $39 - $72
-128 Reduced 46.72%
146 $0
Q4 2023

Feb 14, 2024

BUY
$0.29 - $0.53 $79 - $145
274 New
274 $0
Q4 2022

Feb 10, 2023

BUY
$0.82 - $1.03 $164 - $206
200 New
200 $0
Q1 2022

May 16, 2022

BUY
$1.42 - $2.09 $42,135 - $62,016
29,673 New
29,673 $44,000
Q3 2021

Nov 15, 2021

SELL
$1.42 - $2.0 $3,294 - $4,640
-2,320 Closed
0 $0
Q2 2021

Sep 13, 2021

BUY
$1.21 - $1.89 $2,807 - $4,384
2,320 New
2,320 $4,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $28.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.